Gary Rowe

Gary Rowe is an experienced professional in analytical chemistry with a strong background in pharmaceutical development. As the Manager of Analytical Development at Corden Pharma since September 2018, Gary oversees analytical method development, validation, and regulatory submissions. Prior roles include Director of Analytical Chemistry at miRagen Therapeutics, Analytical Group Leader at Pfizer, and Analytical Scientist III at Hospira, where responsibilities encompassed analytical method development for Active Pharmaceutical Ingredients (API) and process improvements. Gary also led teams at Array BioPharma and held positions at Roche and Merck, building a solid foundation in analytical chemistry through rigorous academic training, including a Ph.D. from Indiana University Bloomington and a Post Doctoral Fellowship from the University of North Carolina at Chapel Hill.